www.i-canadianpharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Moxifloxacin - Avelox, Aventyl, Betapace, Noroxin
Generic Avelox
Generic Avelox is an antibiotic in the class of drugs called fluoroquinolones. It is used to treat bacterial infections.
$12.00
Buy now!
Generic Aventyl
Generic Aventyl is prescribed for the relief of symptoms of depression. It is one of the drugs known as tricyclic antidepressants.
$0.97
Buy now!
Generic Betapace
Generic Betapace is used for treating certain types of irregular heartbeat (ventricular arrhythmias).
$0.69
Buy now!
Generic Noroxin
Norfloxacin (NORFLOXACIN) belongs to a class of drugs called quinolone antibiotics. Norfloxacin is used to treat a variety of bacterial infections
$0.89
Buy now!
Choose Your language:
- Testimonials
-
Hi.
Read more »
just want to say thanks for your promt and efficient service.. The tablets arrived well within the timeframe given.. Have passed on your address, dont know wheather its been used or not..
Best regards... and happy St Patricks from the Irish in France.. - Kieran
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Organ Failure in Sepsis Not Cut with Two Drugs - MedPage Today
- Organ Failure in Sepsis Not Cut with Two DrugsMedPage TodayIn a randomized open-label trial, the combination of meropenem (Merrem) and moxifloxacin (Avelox) did no better than meropenem alone, according to Tobias Welte, MD, of the Medizinische Hochschule in Hannover, Germany, and colleagues
- Indians popping more antibiotics than ever: Study - Times of India
- Indians popping more antibiotics than ever: StudyTimes of IndiaPart A included drugs like Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid and Cefpirome
- 6 Cataract Safety Tips - OutpatientSurgery.net
- 6 Cataract Safety TipsOutpatientSurgery
- MAXSEP-Studie: Kombinationstherapie bringt keinen Vorteil - innovations report
- MAXSEP-Studie: Kombinationstherapie bringt keinen Vorteilinnovations report302 Patienten eine Kombinationstherapie mit Meropenem plus Moxifloxacin
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
